In the original melanoma patient from which TIL1383I was cloned, upregulation of the tyrosinase gene may have served a similar purpose, allowing an otherwise quiescent T cell to expand, drive tumor infiltration, and contribute to tumor rejection. This evidence concerns the gene TYR and neoplasm.